Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
NCT00301236
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
252
Enrollment
INDUSTRY
Sponsor class
Conditions
ADHD, ADD
Interventions
DRUG:
Dexmethylphenidate HCl extended-release capsules
Sponsor
Novartis